Malignant ophthalmopathy presenting one week after radioiodine treatment of hyperthyroidism

Lynn A. Burmeister, Randall L. Beatty, Jack R. Wall

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

A 46-year-old woman presented with malignant ophthalmopathy 1 week after a therapeutic dose of radioiodine for treatment of hyperthyroidism. The patient was a smoker and had clinical evidence of mild thyroid-associated ophthalmopathy (TAO) prior to treatment with radioiodine. Anti-thyrotropin (TSH) receptor antibodies and antiflavoprotein antibodies were not detected at the time of presentation with malignant ophthalmopathy. The patient responded rapidly to anti-inflammatory treatment with intravenous methylprednisolone and orbital radiation.

Original languageEnglish (US)
Pages (from-to)189-192
Number of pages4
JournalThyroid
Volume9
Issue number2
DOIs
StatePublished - Feb 1999

Fingerprint

Dive into the research topics of 'Malignant ophthalmopathy presenting one week after radioiodine treatment of hyperthyroidism'. Together they form a unique fingerprint.

Cite this